Log in
Enquire now
‌

US Patent 10169539 Data backfilling for continuous glucose monitoring

Patent 10169539 was granted and assigned to Dexcom on January, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Dexcom
Dexcom
Date Filed
October 6, 2016
Date of Patent
January 1, 2019
Patent Applicant
Dexcom
Dexcom
Patent Application Number
15287581
Patent Citations Received
‌
US Patent 11547805 Therapy management systems, methods, and devices
0
‌
US Patent 11484657 Intelligent medication delivery systems and methods
0
‌
US Patent 11664107 Intelligent medication delivery systems and methods using a prescription-regulated software application
0
‌
US Patent 11701473 Reusable injection pens
0
‌
US Patent 11771835 Therapy assist information and/or tracking device and related methods and systems
‌
US Patent 11369743 Intelligent medication delivery systems and methods for dose setting and dispensing monitoring
0
‌
US Patent 11383043 Medicine injection and disease management systems, devices, and methods
0
‌
US Patent D960895 Display screen with graphical user interface
‌
US Patent 11878151 Intelligent medication delivery systems and methods for dose setting and dispensing monitoring
0
‌
US Patent 11904145 Diabetes therapy management systems, methods, and devices
0
•••
Patent Inventor Names
Peter C. Simpson
0
Katherine Yerre Koehler
0
Leif N. Bowman
0
Michael Robert Mensinger
0
Phil Mayou
0
Sebastian Bohm
0
Disha B. Sheth
0
Douglas William Burnette
0
Eli Reihman
0
Eric Cohen
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10169539
Patent Primary Examiner
‌
Robert Craddock

Find more entities like US Patent 10169539 Data backfilling for continuous glucose monitoring

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.